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Abstract 
  
We present a rigidity analysis on a large number of X-ray crystal structures of the 
enzyme HIV-1 protease using the ʻpebble gameʼ algorithm of the software FIRST. We find 
that although the rigidity profile remains similar across a comprehensive set of high 
resolution structures, the profile changes significantly in the presence of an inhibitor. Our 
study shows that the action of the inhibitors is to restrict the flexibility of the β-hairpin 
flaps which allow access to the active site. The results are discussed in the context of full 
molecular dynamics simulations as well as data from NMR experiments. 
 
1. Introduction 
 
The relationships between protein structure, rigidity, and function are important in 
biophysics. In this study the software FIRST is used to create rigidity profiles of a set of 
280 X-ray crystal structures of HIV-1 protease that have been solved to a resolution of at 
least 2.0 Å and made available via the protein data bank (PDB). FIRST runs the pebble 
game algorithm [1] to identify rigid clusters and flexible regions within a protein by 
matching atomic degrees of freedom with the constraints present due to bonding, and 
can carry out the rigidity analysis without high computational cost. By rapidly extracting 
information from all of the available high-resolution HIV-1 protease structures we use 
FIRST to build an overview of the information available in the PDB. In a recent study [2], 
FIRST is applied to a set of individual structures from each of six different proteins, one of 
which is HIV-1 protease. Here we examine the enzyme in more detail by making a 
comprehensive study of the high-resolution structures available. 
   Molecular dynamics (MD) studies on structures of HIV-1 protease [3] are informative 
yet computationally intensive and as such cannot offer an overview of the available 
structures. Experimentally, NMR [4] and fluorescence spectroscopy [5] have been used 
to study the flexibility of the protein. HIV-1 protease is a well-documented drug target due 
to its role in the life-cycle of HIV-1 [6] and many inhibitors have been designed in an 
attempt to block HIV-1 replication [7]. The structures have a range of crystallisation 
conditions, inhibitors and mutations. Initial findings from the analysis are presented, and 
work is ongoing to determine other underlying trends in the rigidity data of the 280 
structures. 
 
 
2. Method 
 
In order to prepare the structures for rigidity analysis, all the water molecules are 
removed and the REDUCE software is used to add the hydrogen atoms that are not 
present in the X-ray crystal structure and to flip side chains where necessary. Uninhibited 
protease structures are created in PYMOL by manually by deletion of the inhibitor. A new 
PDB file is created representing the protein in a conformation which is part of the 
ensemble explored by the protein in its natural flexible motion [8]. The MD study in [9] 
also used this method to get structures of the apoenzyme and the holoenzyme. Covalent 
bonds, hydrogen bonds, salt bridges and hydrophobic interactions are included as 
constraints that restrict the freedom of the atoms in a molecule. Weaker, longer-range 
electrostatic forces and van der Waals forces are omitted [10]. FIRST builds a rigidity 
profile of the protein consisting of rigid substructures linked together by flexible sections 
[11]. The profile is calculated at a particular energy cutoff value Ecut, and whilst other 
constraints are maintained, only hydrogen bonds whose energy lie below Ecut are 
included. Constraints are removed as Ecut is lowered and the rigidity profile of the protein 
is modified. Rigid cluster decomposition (RCD) plots show the rigidity profile of the 
protein at each Ecut  value which resulted in a change to the flexibility of a Cα atom in the 
protein backbone. The horizontal axis of an RCD shows the Cα atoms in the primary 
structure of the protein with flexible regions indicated by thin black lines and rigid regions 
by thick coloured blocks. The colour associates each residue with a particular cluster and 
the vertical axis shows the Ecut value used to determine each rigidity profile. Examples of 
RCD plots can be seen in Figure 2. 
As in [2] overall rigidity of the protein is expressed by the function
€ 
f5 , defined in (1). It is 
determined by how many of the Cα atoms are included in the five largest rigid clusters. 
The total number of Cα atoms in the protein is NCα. Rigid clusters are numbered in order 
of decreasing size so that
€ 
ni(Ecut)	  is the number of Cα atoms in rigid cluster 
€ 
i  at cutoff 
value Ecut. 
€ 
f5(Ecut ) =
1
NCα
ni(Ecut )
i=1
5
∑ . (1) 
Rigidity dilution (RD) graphs plot
€ 
f5  against Ecut and show how the rigidity of the main 
chain of the protein is lost as the cutoff value is lowered. 
 
3. Results and discussion 
 
Figure 1 shows two representations of the protein corresponding to Ecut values at the 
beginning 1(a) and towards the end 1(b) of the bond dilution. Rigidity is maintained in two 
α-helices towards the base of the protein and at the centre where the active site is 
located. However, at an Ecut of −1.305 kcal/mol, the protein is almost entirely flexible. The 
same is observed in the structure 1B6J, for which two RCD plots with and without the 
inhibitor are shown in Figure 2. The regions surrounding residues 50 and 150 of the 
protein correspond to the β-hairpin flaps which close over the active site of the enzyme. 
The flaps become flexible much earlier in the bond-breaking process when there is no 
active-site inhibitor present. This overall trend was observed in all of the structures 
studied. Figure 3 shows an RD plot of the structure 1B6J with and without an inhibitor 
attached. In the RD plot, data is recorded in the graph whenever the rigidity of the Cα 
atoms changes. Only when a Cα atom ceases to be part of one of the five largest rigid 
clusters in the protein is
€ 
f5  reduced. This results in the stepwise nature of the plots. With 
no inhibitor, the
€ 
f5  value of 1B6J drops faster with decreasing Ecut, although both 
structures exhibit rapid rigidity loss in agreement with [2]. 
 
 
 
 
 
 
                           (a)           (b) 
 
Figure 1. PYMOL is used to show the structure 1EC0, its inhibitor having been removed. 
The protein is largely rigid in (a) with Ecut = 0 kcal/mol, and flexible in (b), where Ecut = 
−1.305 kcal/mol. The secondary structure is shown in a black ʻcartoonʼ representation, 
and the rigid clusters are shown in different colours for clarity. 
 
 
(a) Inhibited. 
 
(b) Uninhibited. 
 
Figure 2. The RCD plot for the structure1B6J is shown in (a), and with its inhibitor having 
been removed in (b). The thin black lines represent flexible regions of the protein and the 
thick coloured lines show rigid clusters. The columns on the left hand side of the plot 
show the number of remaining hydrogen bonds, Ecut and the mean coordination value 
<r>, which is an indication of the average number of interactions per atom. The rigidity 
loss patterns are similar, however the regions indicated by arrows become flexible at 
higher Ecut in (b) than in (a). 
 
 
 
 
 
                     
 
Figure 3. The RD plot for the protein with PDB code 1B6J. The suffix (U) signifies the 
uninhibited copy of the protein. As Ecut is lowered, rigidity is lost. Main chain rigidity is lost 
more rapidly in the uninhibited copy. 
 
4. Conclusion and outlook 
 
The overall trend in the rigidity analysis of the 280 crystal structures reveals that the main 
effect of the inhibitors is to rigidify the flaps of the enzyme which move to permit access 
to the active site. That the structures studied vary in resolution, inhibitor identity, 
mutations, and crystallisation conditions suggests that this trend is robust against 
structural variation. The results tie in with MD simulations such as [9] and experimental 
evidence [12], where the protein flaps are reported as being mobile in the native state but 
restricted by the presence of an active-site inhibitor. To expand on the analysis using 
FIRST, we are currently exploring the use of the mobility software FRODA in combination 
with elastic network modelling to study predicted protein mobility. 
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